ADVANCED SOLID TUMORS WHICH ARE CMET-DEPENDENT

Clinical trials for ADVANCED SOLID TUMORS WHICH ARE CMET-DEPENDENT explained in plain language.

Never miss a new study

Get alerted when new ADVANCED SOLID TUMORS WHICH ARE CMET-DEPENDENT trials appear

Sign up with your email to follow new studies for ADVANCED SOLID TUMORS WHICH ARE CMET-DEPENDENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Cancer patients get extended access to experimental drug in safety monitoring study

Disease control Ongoing

This study provides continued access to the cancer drug capmatinib for patients who were already receiving it in previous Novartis trials and are still benefiting from it. The main goal is to monitor the long-term safety of the treatment in 29 patients with advanced solid tumors.…

Matched conditions: ADVANCED SOLID TUMORS WHICH ARE CMET-DEPENDENT

Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

ADVANCED SOLID TUMORS WHICH ARE CMET-DEPENDENT

Get alerted when new ADVANCED SOLID TUMORS WHICH ARE CMET-DEPENDENT trials appear

Cancer patients get extended access to experimental drug in safety monitoring study